Microbix Biosystems Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 2, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	33	37	46	42	71	79
Market Cap Growth	-51.76%	-18.87%	9.25%	-41.05%	-9.88%	178.12%
Enterprise Value	31	31	39	35	63	77
Last Close Price	0.24	0.27	0.34	0.30	0.51	0.63
PE Ratio	-	-	12.97	-	39.63	24.33
PS Ratio	1.98	1.99	1.80	2.53	3.72	4.23
PB Ratio	1.25	1.33	1.61	1.70	2.84	4.24
P/TBV Ratio	1.45	1.54	1.90	2.07	3.02	4.65
P/FCF Ratio	-	-	16.84	-	49.24	91.05
P/OCF Ratio	-	-	10.50	-	20.46	37.34
EV/Sales Ratio	1.85	1.69	1.54	2.12	3.28	4.17
EV/EBITDA Ratio	-	-	7.55	-	18.80	14.38
EV/EBIT Ratio	-	-	10.06	-	23.97	16.02
EV/FCF Ratio	-7.32	-	14.46	-	43.46	89.69
Debt / Equity Ratio	0.26	0.24	0.23	0.27	0.23	0.42
Debt / EBITDA Ratio	-	105.91	1.19	-	1.66	1.40
Debt / FCF Ratio	-	-	2.36	-	4.05	8.95
Net Debt / Equity Ratio	-0.08	-0.19	-0.23	-0.20	-0.31	-0.12
Net Debt / EBITDA Ratio	0.99	38.23	-1.26	2.62	-2.30	-0.42
Net Debt / FCF Ratio	0.53	6.08	-2.42	2.35	-5.32	-2.61
Asset Turnover	0.44	0.49	0.69	0.48	0.62	0.84
Inventory Turnover	1.09	1.12	1.64	1.64	1.64	1.74
Quick Ratio	4.26	4.94	5.05	3.63	6.25	2.73
Current Ratio	7.51	8.48	7.15	5.13	8.45	3.68
Return on Equity (ROE)	-15.38%	-8.01%	13.30%	-0.16%	8.22%	25.69%
Return on Assets (ROA)	-5.93%	-2.61%	6.60%	-4.97%	5.27%	13.61%
Return on Invested Capital (ROIC)	-15.39%	-7.13%	18.05%	-14.82%	14.90%	33.35%
Return on Capital Employed (ROCE)	-10.70%	-4.60%	11.20%	-8.70%	8.60%	20.50%
Earnings Yield	-12.84%	-6.06%	7.71%	-0.09%	2.52%	4.11%
FCF Yield	-12.75%	-2.37%	5.94%	-5.05%	2.03%	1.10%
Buyback Yield / Dilution	-1.38%	-0.48%	-0.42%	2.67%	-0.00%	-35.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.